Literature DB >> 2689632

Improvement of systemic absorption of insulin through eyes with absorption enhancers.

G C Chiou1, C Y Chuang.   

Abstract

A painless, simple, and practical method has been developed for systemic delivery of peptide drugs through eyes. In order to increase the amount of peptides absorbed into systemic circulation, effects of enhancers on insulin absorption into systemic circulation and reduction of blood glucose concentration have been studied. Saponin showed the highest potency to enhance insulin absorption, while Tween 20 was the least effective. The efficacy order of seven compounds studied can be arranged as follows: saponin greater than fusidic acid greater than BL-9 = EDTA greater than glycocholate = decamethonium greater than Tween 20. Since 1% of saponin reached the maximum effect to enhance insulin absorption and decrease blood glucose concentration, not more than 1% of saponin should be used for enhancing peptide absorption through eyes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2689632     DOI: 10.1002/jps.2600781007

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

Review 1.  Pharmacokinetic considerations of new insulin formulations and routes of administration.

Authors:  A Hoffman; E Ziv
Journal:  Clin Pharmacokinet       Date:  1997-10       Impact factor: 6.447

2.  A semisynthetic Quillaja saponin as a drug delivery agent for aminoglycoside antibiotics.

Authors:  J Recchia; M H Lurantos; J A Amsden; J Storey; C R Kensil
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

3.  Enhanced bioavailability of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats.

Authors:  F Ahsan; J Arnold; E Meezan; D J Pillion
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

4.  Ocular tolerance of absorption enhancers in ophthalmic preparations.

Authors:  Pascal Furrer; Joachim Michael Mayer; Bernard Plazonnet; Robert Gurny
Journal:  AAPS PharmSci       Date:  2002
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.